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 Original Article 
Surgical Interventions for Renal Cell Carcinoma 
with Thrombus Extending into the Inferior Vena 
Cava: A Multidisciplinary Approach
Zia Ur Rehman, MBBS, FCPS, ChM,1 M Hammad Ather, MBBS, FCPS, FRCS,2  
and Wajahat Aziz, MBBS, FCPS2
Objective: To assess surgical strategies and the impact of a 
multidisciplinary approach on patients undergoing inferior 
vena caval thrombectomy for renal cell carcinoma and to 
evaluate perioperative morbidity and mortality associated 
with these procedures.
Methodology: A retrospective audit for all adults who 
underwent nephrectomy and inferior vena caval thrombec-
tomy from January 2008 till November 2018 at a University 
hospital. Patients with incomplete records were excluded 
from the study.
Results: During the study period, 21 patients underwent 
inferior vena caval thrombectomy as a completion of radi-
cal nephrectomy. Most were males (19 : 2) with a mean age 
of 54±11.3 years. The most common surgical approach 
was the 11th rib flank approach (n=8) followed by midline 
abdominal (n=6) and Mercedes-Benz (n=5). Eight patients 
had level 1, 10 patients had level 2, and three patients had 
level 3 tumour thrombus. The cavotomy was closed pri-
marily in 20 patients; one required inferior vena cava (IVC) 
reconstruction with a pericardial patch. The proximal clamp 
was applied below the hepatic veins for most patients. Two 
patients required suprahepatic clamping before thrombec-
tomy. There was no intraoperative mortality. Five patients 
(24%) developed complications: two required cardiopul-
monary resuscitation due to severe hypotension and were 
revived; one developed acute renal failure; and one patient 
required a damage control laparotomy for excessive oozing. 
There was no thirty-day mortality.
Conclusion: The IVC thrombectomy, along with radical ne-
phrectomy for renal cell carcinoma for 1–3 level thrombus, 
can be performed with acceptable morbidity in a multidisci-
plinary team approach.
Keywords: carcinoma, renal cell, vena cava, inferior, throm-
bosis
Introduction
In about 4% to 19% of patients with renal cell carcino-
mas (RCCs), tumours extend into the inferior vena cava 
(IVC).1) IVC thrombus in RCC patients has a signiﬁcant 
adverse impact on the overall prognosis. Surgical extirpa-
tion of both renal tumour and IVC is the standard treat-
ment option. Performing tumour thrombectomy in the 
IVC is associated with better outcomes in this subgroup 
of patients.2) Since there are few alternative management 
options, like systemic therapy and radiotherapy, aggres-
sive surgical removal of the tumour and thrombus remains 
the primary option for patients.3,4) Current evidence does 
not associate a higher level of thrombus with accelerated 
tumour dissemination to lymphatics in the perinephric fat 
or distantly. Preoperative embolization is associated with 
increased morbidity,5) and use of IVC ﬁlters remains un-
certain. The best approach for surgical treatment of these 
patients remains unclear. The study objectives are to assess 
surgical strategies for patients undergoing IVC thrombec-
tomy for renal cell carcinoma with thrombus extending 
into the IVC and to evaluate associated perioperative 
morbidity and mortality.
Methodology
We conducted a retrospective audit of adult patients (>18 
years) who underwent tumour nephrectomy and IVC tu-
mour removal at a University hospital from January 2008 
through November 2018. The Institutional Review Board 
granted an exemption for this study (2018-0583-568). All 
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patients had surgery performed under general anesthesia.
Computed tomography (CT) of the abdomen was per-
formed before surgery, and the tumours were classiﬁed 
into four categories, according to the cranial extension 
of the thrombus into the IVC, as described by Neves and 
Zincke.6) The patients were approached through midline, 
subcostal, chevron or Mercedes-Benz incisions, depending 
on patient habitus, tumour size, tumour thrombus level, 
and surgeon experience. The speciﬁc surgical technique 
was selected on the thrombus extension level. This also 
guided the surgical approach and teams to be involved. 
We had excellent communication with anesthesia and the 
blood bank teams. For level 1 and 2 tumour thrombus, 
both the urology and vascular surgery teams usually work 
in tandem for minimal IVC handling until the proximal 
extent is deﬁned and controlled. For a level 1 tumour, 
a cavotomy was performed and the tumour removed 
after control of the proximal and distal vena cava and 
contralateral renal vein. If the tumour were limited to the 
renal vein, a tumour thrombectomy was performed, with 
little dissection, after applying only a side-biting clamp. 
Primary repair was performed if there were no signiﬁcant 
vein defect; if there were, patch repair was considered. For 
a level 2 tumour, IVC control above the thrombus was 
more difﬁcult; it required hepatic mobilization in case of 
retrohepatic extension. After getting control of the infra-
renal IVC, contralateral renal vein, and supra renal IVC, 
the tumour thrombus was removed en bloc if possible. For 
level 3 tumours, the hepatic surgery team was involved. 
The same control was achieved, but the proximal clamp 
was applied to the suprahepatic area. The patient was 
placed in the reverse Trendelenburg position. The liver 
was rolled to the patient?s left, and the IVC was opened 
along the anterolateral aspect to the level of the hepatic 
veins. After complete hepatic mobilization, the supra he-
patic IVC, infra renal IVC, contralateral renal vein, and 
hepatoduodenal ligaments were occluded sequentially 
to perform the thrombectomy in a bloodless ﬁeld. The 
surgical team would then complete the nephrectomy and 
remove the specimen. The thrombus was removed en bloc 
through longitudinal cavotomy, but in some instances, it 
adhered to the wall and was removed piecemeal. Every ef-
fort was made to ensure there was no residual thrombus in 
the proximal portion by back bleeding before ﬁnal closure 
of the cavotomy. To prevent air embolism, the patient was 
placed in a Trendelenburg position for back bleeding from 
the proximal end.
Patients with incomplete follow-up or incomplete re-
cords were excluded from the study. All the data were 
collected retrospectively from patients? medical records 
on specially designed proforma. The data included patient 
demographics, comorbidities, tumour thrombus levels, in-
cision for exposure, surgical strategy use, total blood loss 
(ml), total operative time (h), intensive care unit (ICU) stay 
(days), total hospital stay (days), perioperative morbidity 
and mortality.
The data was analyzed on SPSS version 20.0 (IBM 
Corp., Chicago, IL, USA). Descriptive statistics were re-
ported for the quantitative variable as mean±standard 
deviation (SD)/Median (interquartile range [IQR]) and for 
categorical variables was reported as frequency (%).
The outcome measures were mortality (intraoperative 
or within 30 days postoperatively), morbidity, ICU stay, 
and blood loss.
Results
During the study period, 21 patients underwent IVC 
thrombectomy to complete the radical nephrectomy 
(Table 1). Most were males (19 : 2) with a mean age of 54 
(SD±11.3) years. The most common surgical approach 
was the 11th rib retroperitoneal/extra pleural approach 
(n=8) followed by midline (n=6) and Mercedes-Benz 
(n=5). Eight patients had a level 1, 10 patients had a level 
2, and three patients had a level 3 tumour extension. No 
patients had tumour extension into the right atrium. The 
most common procedure was radical nephrectomy and 
IVC thrombectomy with primary closure. In one patient, 
IVC was reconstructed with a pericardial patch (Table 1). 
Table 1 Basic demographic data, surgical approaches em-
ployed, IVC closure technique and vascular control 
technique 
n=21
Mean age (years) (±SD) 54.8 (±11.3)
Gender (male : female) 19 : 2
Side of tumour (right : left) 18 : 3
Level of tumour thrombus
Level 1 8 (35%)
Level 2 10 (50%)
Level 3 3 (15%)
Level 4 0 (0%)
Surgical approaches
Midline 6 (30%)
Subcostal 8 (35%)
Mercedes-Benz 5 (25%)
Thoracoabdominal 1 (5%)
Chevron 1 (5%)
IVC reconstruction
Primary closure 20 (95%)
Patch closure of IVC 1 (5%)
Level of proximal clamping
a. Sub hepatic 14 (70%)
b. Retro hepatic below hepatic veins 4 (20%)
c. Supra hepatic 2 (10%)
IVC: inferior vena cava; SD: standard deviation
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Distant metastasis was identiﬁed in four patients preoper-
atively. The proximal clamp was placed below the hepatic 
veins except for two patients who required suprahepatic 
clamping before thrombectomy (Table 1). Nephrectomy 
was performed ﬁrst with ligation and division of the renal 
artery and vein; the kidney was removed for better ac-
cess. After exposure and clamping of the IVC, the tumour 
thrombi were removed through an anterior cavotomy. 
The mean operative blood loss was 2,893 ml (±2,447). 
The mean operative time was 4.5 h (Table 2). There was 
no intraoperative mortality. Two patients required cardio-
pulmonary resuscitation (CPR) due to severe hypotension 
and were revived. One patient developed acute kidney 
injury; however, it resolved with conservative treatment. 
One patient with a relatively larger renal tumour devel-
oped hypothermia and coagulopathy at the end of the 
operation. There was excessive oozing from the dissection 
bed. The patient required a damage control laparotomy 
and the abdomen was closed after 48 h (Table 2). Most 
of the tumour thrombectomies were accomplished via the 
11th rib approach, which was common for level 1 tumour 
thrombus, while the Mercedes-Benz was used for level 3 
tumours (P-value=0.02) (Table 3).
More blood loss tended to occur with increased tumour 
thrombus levels. Higher tumour thrombus levels were also 
associated with longer operation times (Table 4).
Discussion
The American Cancer Society?s most recent estimates for 
kidney cancer in the United States indicate there were 
nearly 63,340 new cases of kidney cancer (42,680 in men 
and 22,660 in women) in 2018. Approximately 14,970 
people (10,010 men and 4,960 women) will die from 
this disease.7) RCC has a biological predisposition for 
direct vascular invasion. Intravascular tumour thrombus 
is found in 10%–40% of patients with RCC in the renal 
vein or IVC.8) IVC thrombus is a poor prognostic indi-
cator, with a life expectancy of less than six months in 
untreated cases.9) A radical nephrectomy and cava throm-
Table 2 Outcome variables showing total blood loss, mean 
operative time (from incision to wound closure), total 
hospital stay, ICU stay and different complications
Variables n=21
Total estimated blood loss (ml) (±SD) 2893 (±2447)
Total operative time (h) (±SD) 4.7 (±1.4)
Total hospital stay (days) (±SD) 8.3 (±3.61)
Mean ICU stay (days) 4.5
Perioperative complications
Pulmonary embolism 1
Acute renal failure 1
Severe intraoperative hypotension 
(requiring CPR)
2
Severe hypothermia 1
30-day mortality 0
ICU: intensive care unit; SD: standard deviation; CPR: cardio-
pulmonary resuscitation
Table 3 Different surgical approaches, proximal clamping, perioperative complications, and ICU stay between different thrombus levels
Variables
Level 1 Level 2 Level 3
P-value
(n=8) (n=10) (n=3)
Male 8 (100%) 8 (80%) 3 (100%) 0.632
Right sided of tumour 7 (100%) 8 (80%) 3 (100%) 0.632
Surgical approaches 0.022
a. Subcostal 7 (90%) 1 (10%) 0 (0.0%)
b. Mercedes-Benz 0 (0.0%) 3 (30%) 2 (66.7%)
Suprahepatic clamping 0 (0.0%) 0 (0.0%) 2 (66.7%) 0.016
Perioperative complications 1 (14.3%) 1 (10%) 2 (66.6%) 0.06
ICU stay (days) 0 (0.0%) 3 (30%) 3 (99.9%) 0.03
T3 N0 Mx 5 (71.4%) 7 (70%) 1 (33.3%) 0.355
ICU: intensive care unit
Table 4 Differences in total blood loss (ml), total operative time (h) and total hospital stay (days) between different levels of tumour 
thrombus
Level 1 Level 2 Level 3
P-value
(n=3) (n=10) (n=3)
Total EBL (median) (IQR) 1,000 (670–1,800) 2,250 (1,500–6,250) 4,000 (1,500–4,000) 0.07
Total operative time (h) (median) (IQR) 3.75 (3.00–5.00) 5.25 (4.37–6.00) 5.50 (4.1–5.00) 0.134
Total hospital stay (days) (median) (IQR) 6 (5.00–7.00) 8 (6.5–12.00) 10 (7.00–10.00) 0.055
EBL: estimated blood loss; IQR: interquartile range
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bectomy is one of the most potent management strategies 
associated with long-term survival. Radical extirpative 
surgery, with nephrectomy and IVC thrombectomy, only 
provides medium term survival.10) In a recently reported 
large series, Master et al.11) noted that resection of RCC 
with IVC tumour thrombus yields long-term survival. 
Haferkamp et al.12) noted that patients with metastatic 
disease, IVC thrombus, and RCC have better survival with 
surgical extirpation followed by tyrosine kinase inhibitors 
(TKI). For RCC patients without distal metastases who 
undergo radical nephrectomy and IVC tumour throm-
bectomy, the ﬁve-year survival rate has been reported to 
be 45%–69%.13) Temporary ﬁlters and liver mobilization 
techniques improve the safety and prognosis of radical ne-
phrectomy and IVC thrombectomy in renal cell carcinoma 
with subdiaphragmatic thrombosis.
Berg was the ﬁrst to report nephrectomy and cavotomy 
to treat RCC with tumour thrombus extending into the 
IVC.14) Since Berg?s ﬁrst report, radical nephrectomy with 
vena cavotomy has become a safe and effective treatment 
for RCC with IVC thrombus. The 30-day mortality for 
radical nephrectomy with IVC thrombectomy has been 
reported to be 1.5%–10%, and the complication rates 
have been reported to be 18%, 20%, 26%, and 47% 
for IVC tumour thrombus level I, II, III, and IV disease, 
respectively.15) Fortunately there was no 30-day mortality 
in our series. The complication rate is 30%, which is com-
parable to the contemporary series. We consider this to 
our multidisciplinary approach. Most of the patients with 
level 1 were approached through ﬂank or subcostal inci-
sion. This depended on the individual tumour size and the 
surgeon choice. If the tumour thrombus was higher, wider 
incisions were used. More patients were approached via 
Mercedes-Benz or chevron incisions. The wider exposure 
did help complete this radical procedure safely. Although 
level 1 tumours do not require any complex maneuvers, 
except for control of the IVC above and below the tumour, 
level 2 and 3 tumours require more complex maneuvers. 
There was a patient in with level 1 who had catastrophic 
bleeding while undergoing dissection around the renal 
vein. He ended up in acute renal failure. This highlights 
the practical difﬁculty while dissecting around these tu-
mours when the natural planes are lost, tissues are thick, 
and the hyperemic anatomy is distorted. Getting adequate 
exposure was always helpful.
One of the challenges is managing these patients? hemo-
dynamic disturbances as they undergo thrombectomies. 
Whereas temporary occlusion of the infrahepatic IVC can 
be safely be done for level 1 tumours, the occlusion of 
the suprahepatic IVC often causes a profound decrease in 
venous return, resulting in hypotension. Before applying 
clamps, patients were well hydrated and were hemody-
namically stabilized. There was also a check of clamping, 
for a minute, for hemodynamic disturbances before pro-
ceeding to cavotomy. There are various ways, described 
during IVC thrombectomy and nephrectomy, to prevent 
intraoperative hypotensive shock and pulmonary embo-
lism. These include veno-venous bypass, cardiopulmonary 
bypass, and deep hypothermic circulatory arrest. How-
ever, there are alternate ways to control vessels, including 
IVC and hepatic pedicle sufﬁces. In a recent report Chen 
et al.16) showed the safety of treating level III IVC, con-
comitant to RCC, by precisely controlling IVC and hepatic 
vessels without a vascular bypass.
Two patients had severe hypotension after proximal 
clamp application, but were revived with brief cardiopul-
monary resuscitation. The various strategies mentioned in 
literature to deal with these hemodynamic changes, from 
proximal clamping as veno-venous bypass, were backup 
strategies for our patients. None of them required it. We 
retrospectively think that using these strategies proactively 
would have avoided these hemodynamic changes.
Renal tumours often invade the vena cava wall, regard-
less of thrombus level.17) One patient with this invasion 
required IVC reconstruction with a pericardial patch.
The median blood loss in this case series ranges from 
1,000 ml for level 1 to 4,000 ml for level 3. This signiﬁes 
need to continuously resuscitate these patients intraop-
eratively. We also employed damage-controlled strategies 
when needed in an occasional patient. As mentioned, one 
patient had level 2 thrombi. During dissection for the 
nephrectomy and thrombectomy, the patient experienced 
oozing and was on the verge of becoming hypothermic at 
the end of operation. It was decided to temporarily pack 
the abdomen and resuscitate the patient in the ICU. The 
patient was revived and returned to the operating room 
after 48 h for removal of packs and deﬁnitive closure of 
the abdomen.
One of our patients had a pulmonary embolus that was 
not present before surgery. The embolus was suspected 
on a routine postoperative chest X-ray and subsequently 
conﬁrmed on chest CT. Indeed, pulmonary metastases 
from IVC thrombus are not well highlighted in the lit-
erature. The follow-up of this patient indicated multiple 
lung metastatic deposits in a scan three months after IVC 
thrombectomy. Soon after the surgery he was placed on 
TKI. Pulmonary embolism is indeed a devastating com-
plication caused by tumour thrombus shedding due the 
manipulation of the IVC during surgery; the mortality rate 
could be up to 75%.18)
For high-risk patients, the European Association for 
Urology (EAU) guidelines recommend the ﬁrst CT six 
months after surgery and, subsequently, once a year up to 
three years and every two years afterwards. A recent re-
port by Elahmadawy et al.,19) about detection of local and 
distant disease relapse in surgically treated patients with 
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RCC, indicated that local and/or distant disease relapse 
was conﬁrmed in 72% of patients. Regarding local recur-
rence, ﬂuorodeoxyglucose positron emission tomography-
computed tomography (FDG PET-CT) showed speciﬁcity 
of 100%, compared to 98.6% with contrast-enhanced CT 
(P>0.05) and higher sensitivity noted with contrast-en-
hanced CT (100%) compared to 96% with FDG PET-CT.
The limitations of this study are that it is retrospec-
tive and from a single institute. Despite these limitations, 
it appears to be safe to perform an IVC thrombectomy 
with a multidisciplinary approach in a developing world 
university.
Conclusion
The IVC thrombectomy, along with radical nephrectomy 
for renal cell carcinoma, can be performed with acceptable 
morbidity and mortality in level 1 to 3 tumour thrombus 
extension.
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